What is the recommended intramuscular (IM) dose of ceftriaxone for a patient with a complicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ceftriaxone IM Dosing for Complicated UTI

For complicated urinary tract infections, administer ceftriaxone 1-2 g intramuscularly once daily, with the 2 g dose preferred for severe infections or when local resistance patterns warrant broader coverage. 1

Dosing Recommendations

The standard IM dose is 1 g once daily, but 2 g once daily is recommended for complicated UTIs in males (who by definition have complicated infections) and for pyelonephritis. 1 This higher dose provides optimal coverage against common uropathogens including E. coli and Klebsiella pneumoniae, which account for approximately 75% of complicated UTI cases. 1

  • The FDA-approved pharmacokinetics demonstrate that 1 g IM achieves peak plasma concentrations of 68 mcg/mL at 2-3 hours post-injection, with urinary concentrations of 504-628 mcg/mL in the first 2-4 hours. 2
  • Clinical studies confirm efficacy of 1-2 g once daily dosing for complicated UTIs, with bacteriologic eradication rates of 86-91%. 3, 4

Clinical Context and Rationale

Ceftriaxone is first-line empiric parenteral therapy for complicated UTIs and pyelonephritis, particularly when fluoroquinolone resistance exceeds 10% in the community. 5, 1

  • Males with UTI are classified as complicated by definition, making parenteral ceftriaxone appropriate initial therapy. 1
  • Extended-spectrum cephalosporins like ceftriaxone are recommended for hospitalized patients or those requiring urgent treatment. 5
  • A single IM dose can serve as initial therapy before transitioning to oral antibiotics once clinically stable. 5, 1

Administration Strategy

Always obtain urine culture (and blood cultures if systemically ill) before administering antibiotics, but do not delay treatment waiting for results. 1

  • Administer the full dose as a single daily injection. 2, 3
  • The long half-life (5.8-8.7 hours) and high protein binding (85-95%) support once-daily dosing. 2
  • Clinical improvement should occur within 48-72 hours; lack of improvement warrants imaging to exclude obstruction or abscess. 1

Transition to Oral Therapy

After initial IM dose(s), transition to oral therapy based on culture susceptibility once the patient is clinically improving (typically 24-48 hours). 1

  • Oral fluoroquinolones (ciprofloxacin 500-750 mg twice daily or levofloxacin 750 mg daily) are preferred for step-down if the organism is susceptible. 1
  • If fluoroquinolone-resistant, consider oral cephalosporins like cefpodoxime 200 mg twice daily or cefuroxime 500 mg twice daily. 1, 6
  • Total treatment duration should be 7-14 days, with 14 days recommended for men when prostatitis cannot be excluded. 1

Important Caveats

Consider imaging (ultrasound initially) to rule out obstruction or abscess, especially if the patient remains febrile after 72 hours or deteriorates. 1

  • Complicated UTIs require culture-guided therapy due to higher resistance rates and anatomical abnormalities. 6
  • Local antibiogram patterns should guide empiric choices, and therapy must be tailored based on susceptibility results. 5
  • The 2 g dose is particularly important when dealing with severe infection, male patients, or when prostatitis is suspected. 1

References

Guideline

Ceftriaxone IM for Male UTI/Pyelonephritis with Pending Cultures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ceftriaxone for once-a-day therapy of urinary tract infections.

The American journal of medicine, 1984

Research

[Clinical studies on ceftriaxone in complicated urinary tract infections].

Hinyokika kiyo. Acta urologica Japonica, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oral Step-Down Therapy for Complicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is Ceftriaxone (Ceftriaxone) 2gm IV sufficient for treating a urinary tract infection (UTI) in a patient with a ureteral stent?
Can ceftriaxone be given alone for urinary tract infections (UTIs)?
Can a patient with a urinary tract infection and green discharge with a Foley catheter be treated with ceftriaxone (Ceftriaxone) 1g intravenous (IV) every 24 hours for 10 days?
What is the appropriate dosage of Ceftriaxone (Ceftriaxone) for treating a urinary tract infection (UTI)?
What is the recommended dose of ceftriaxone (a third-generation cephalosporin antibiotic) for the treatment of a urinary tract infection (UTI)?
What is the recommended intravenous (IV) antibiotic (abx) regimen for an elderly patient with aspiration pneumonia and potential comorbidities?
What is the recommended dosage of Actos (pioglitazone) for an adult patient with type 2 diabetes, considering factors such as renal impairment and history of heart failure?
Is Eliquis (apixaban) bound to albumin in adults with normal renal and hepatic function?
What can I use as an alternative to glyburide (a sulfonylurea) in a patient with impaired glucose regulation, currently on metformin (biguanide) 500mg twice daily, given that insurance is no longer covering glyburide?
What is the management approach for an adult patient with an enlarged heterogeneous thyroid gland due to goiter, potentially from an area with iodine deficiency or a family history of thyroid disorders?
In a patient with isolated hypertriglyceridemia, should statin therapy be initiated or should dietary changes and lifestyle modifications be discussed first?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.